Evoke Pharma Announces Collaboration with Spaulding Clinical Research for the Gimoti Comparative Exposure Pharmacokinetic Trial Read more about Evoke Pharma Announces Collaboration with Spaulding Clinical Research for the Gimoti Comparative Exposure Pharmacokinetic Trial
Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma's Proposed Comparative Exposure PK Trial for Gimoti NDA Read more about Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma's Proposed Comparative Exposure PK Trial for Gimoti NDA
Evoke Pharma's Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017 Read more about Evoke Pharma's Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017
Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results Read more about Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results
Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Full-Year 2016 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Full-Year 2016 Financial Results
Evoke Pharma Announces Full Exercise of Underwriter's Option to Purchase Additional Shares Read more about Evoke Pharma Announces Full Exercise of Underwriter's Option to Purchase Additional Shares
Evoke Pharma Announces Pricing of Public Offering of Common Stock Read more about Evoke Pharma Announces Pricing of Public Offering of Common Stock
Evoke Pharma Announces Proposed Public Offering of Common Stock Read more about Evoke Pharma Announces Proposed Public Offering of Common Stock
FDA Exempts Evoke from Requirement for Human Factor Validation Study Read more about FDA Exempts Evoke from Requirement for Human Factor Validation Study
Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference Read more about Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference